Four things to know:
1. Proteus Digital Health, a company that developed ingestible sensors to detect when medications are taken, filed for Chapter 11 bankruptcy on June 15.
2. The company was valued at $1.5 billion in April 2019, according to Forbes. It aimed to help prevent patients from forgetting to take medications.
3. Proteus has about $100 million to $500 million in assets and $50 million to $100 million in liabilities. Its creditors include Workday and Otsuka America Pharmaceutical, which the company had planned to partner with in 2017. Otsuka invested $88 million in Proteus, but the deal was terminated in January.
4. While the company has struggled in recent months to raise money, it has raised more than $500 million in venture capital. Proteus has also initiated a sale process.
“Filing for bankruptcy protection allows Proteus to continue its sales process in a more concerted and efficient manner while continuing to run the business as usual,” according to a statement from the company.
More articles on digital transformation:
Health IT deals on track to hit $15 billion in Q2: 5 things to know
Northwell Health, University Hospitals join $12M funding round for virtual care company
Cleveland Clinic Ventures had 7 spinoffs, invested $10M in 10 companies last year
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
